DRTECH CFO Lee Gil-su Acquired 80,000 Shares through Open Market Purchase, Signaling Management Confidence but Limited Impact on Shareholder Value

DRTECH registered executive and CFO Lee Gil-su purchased 80,000 common shares at 1,214 KRW per share on June 23, 2026, increasing his stake to 0.89 percent.
This acquisition represents less than 0.1 percent of total outstanding shares, resulting in negligible dilution and potentially serving as a positive signal of insider confidence.
The transaction was executed at a price close to the market price, with no special discount or lock-up provisions, and does not involve any corporate capital change.
[AI Summary]Lee Gil-su's open market purchase reflects insider confidence but is small in scale and does not directly impact the company's financial structure or growth strategy. Shareholders may view it as a mild positive signal, but it is not a material event.